Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Werewolf Therapeutics (HOWL) Return on Capital Employed (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Return on Capital Employed for 5 consecutive years, with 1.58% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 96.0% to 1.58% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.58% through Dec 2025, down 96.0% year-over-year, with the annual reading at 0.98% for FY2025, 44.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 1.58% at Werewolf Therapeutics, down from 1.05% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.24% in Q3 2023, with the low at 1.58% in Q4 2025.
  • Average Return on Capital Employed over 5 years is 0.53%, with a median of 0.39% recorded in 2022.
  • The sharpest move saw Return on Capital Employed increased 19bps in 2023, then crashed -96bps in 2025.
  • Over 5 years, Return on Capital Employed stood at 0.3% in 2021, then crashed by -31bps to 0.39% in 2022, then skyrocketed by 34bps to 0.26% in 2023, then tumbled by -140bps to 0.62% in 2024, then crashed by -154bps to 1.58% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 1.58%, 1.05%, and 0.86% for Q4 2025, Q3 2025, and Q2 2025 respectively.